Hematology

The Pharmacy Times® Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of blood disorders, including blood and bone marrow cancers, leukemia, and myeloma.

Latest News

CAR T-cell therapy injected into tumor cell 3D visualization | Image Credit: © john - stock.adobe.com

Targeted Therapy Brings Remission in Patient With CAR-Positive T-Cell Lymphoma

By Alexandra Gerlach, Associate Editor

August 25th 2025

A patient, who formerly had previously been treated with CAR therapy for multiple myeloma, achieved remission for both multiple myeloma and lymphoma.

FDA - U.S Food & Drug Administration | Image Credit: Luciano Luppa | stock.adobe.com

Rusfertide Gains Breakthrough Therapy Designation for Polycythemia Vera

By Danielle Valletti, Assistant Editor

August 25th 2025

Ibrutinib, Imbruvica tablets | Image Credit: © CLShebley - stock.adobe.com

Ibrutinib–Venetoclax Outperforms Ibrutinib Alone and FCR in Long-Term CLL

By Alexandra Gerlach, Associate Editor

August 21st 2025

Immunoglobulin in IV | Image Credit: © Trsakaoe - stock.adobe.com

Immunoglobulin Replacement Therapy Fails to Lower Hospitalizations in CLL, Study Finds

By Alexandra Gerlach, Associate Editor

August 19th 2025

Multiple myeloma cells illustrated in the bone marrow | Image Credit: © Khella - stock.adobe.com

Bone Marrow Microenvironments Vary Widely in Multiple Myeloma, Study Finds

By Alexandra Gerlach, Associate Editor

August 19th 2025

Latest CME Events & Activities

More News

The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership

July 3rd 2012

The Leukemia & Lymphoma Society (LLS) and Celator Pharmaceuticals, Inc announced a significant expansion of their partnership to support clinical development of Celator's CPX-351 (cytarabine:daunorubicin) liposome injection for treatment of adults with acute myeloid leukemia (AML).